08043004
US tariffs on Indian pharma exports have exemptions
Generic medicines make up about 90% of India's pharma exports to the US and are currently exempt from the 100% US tariff on patented drugs. The exemption is temporary and may change in the future.
The US tariff applies to patented drugs and their ingredients under Section 232 of the Trade Expansion Act of 1962. Generics, biosimilars, and related inputs are exempt for now, but the exemption has limits and may be reviewed within a year of 2 April 2026.
Source: multibagg.ai



